Daily Top 50 Gainers & Losers

Market Regime — the colored bar under each day is the market's overall “weather,” scored from the indexes (trend, fear/VIX, small-cap breadth). It's market-wide context, not a stock pick: even a great company gets dragged down in a red tape. Read it to gauge when to lean in vs. wait for calmer water — click any day for the full read.

Risk-On · supportive Neutral Risk-Off · headwind Stress · fear

Market Recap · Friday, May 29, 2026

Snapshot: May 29, 2026 · 6:00 PM 99 stocks analyzed

Flat Day

Fri, May 29, 2026 Divergent High

Divergent tape with small-cap collapse and tech-led gainers: Russell 2000 fell 0.59% while S&P edged up 0.23% and NASDAQ rose 0.22% in a wild dispersion day.

50% Russell 2000 fell 0.59% while large-cap indices posted modest gains, marking a sharp small-cap selloff that fractured the market into competing narratives despite broad index flatness and VIX easing 2.6%.
30% Extreme dispersion with 50 gainers averaging +41.8% (max DEVS +140%) and 49 losers averaging -22.8% (max POAS -80.5%), led by news-driven surges in DELL (+33%, AI server demand), OKTA (+30%, earnings beat), and NTAP (+22%, strong guidance).
20% Healthcare dominated losers at 26% of the list while Technology led gainers at 27%, signaling sector rotation out of health into infrastructure plays; micro-cap debutants STG, PRFX, MYND, OKTG, and SPCE all erupted >36% on first reappearances with company-specific catalysts.

ADTX on a 7-day losers streak 5 names returned after long absences ADTX · 7-day losers streak ASTC · 3-day gainers streak STG — first appearance PRFX — first appearance

Market Regime

Fri, May 29, 2026 Risk-On conf: high macro · prototype

+49

Tailwind −100 … +100 · + tailwind / − headwind

VIX15.3 p14 Drawdown0.0% Held7d · established SinceMay 21

Top drivers: VIX percentile ▲ S&P vs 50d avg ▲ S&P 20d return ▲

processId: history-market-regime

Market Indexes

Fri, May 29, 2026 4

S&P 500

7,581.25

+17.62

+0.23%

NASDAQ Composite

26,976.35

+58.88

+0.22%

Russell 2000

2,919.36

−17.21

-0.59%

VIX

15.33

−0.41

-2.60%

Biggest Gainers

Fri, May 29, 2026 50

DEVS

DevvStream Corp. Common StockIndustrials

$0.30+$0.18

+140.0%

NASDAQ · Mkt cap $4.8 M

DevvStream announced that its three-party business combination with XCF Global and Southern Energy Renewables remains on track, likely triggering a 140% rally in a micro-cap stock on deal confirmation.

The headline confirms that the proposed business combination involving DevvStream, XCF Global, and Southern Energy Renewables has not fallen apart and continues as planned. For a stock trading at $0.30, this type of M&A confirmation can be a major catalyst, especially if the deal had faced uncertainty or if investors feared termination. Micro-cap NASDAQ stocks are typically more volatile and responsive to corporate action news than larger equities. The fact that this is positioned as a confirmation "remains on track" suggests prior doubt existed about the deal's viability, making the reassurance material to shareholders. However, the headline snippet is truncated and does not specify deal terms, expected close date, or any new positive developments beyond the continuation itself.

HUBC

HUB Cyber Security Ltd.Technology

$0.26+$0.15

+137.4%

NASDAQ · Mkt cap $23 M

New investor ownership filings in HUB Cyber Security triggered a massive rally, with the stock soaring over 350% intraday as large stakes were disclosed, signaling heightened institutional or strategic interest in the micro-cap security.

The Yahoo Finance headline directly attributes the stock's explosive move to a series of investor disclosures revealing sizable stakes in HUB Cyber Security. The timing between the premarket and intraday surge on 2026-05-29 aligns with these ownership filings becoming public. For a micro-cap cybersecurity stock trading at $0.26, new material stakes by identifiable investors—especially if they suggest strategic intent, activist involvement, or large-scale accumulation—can catalyze sharp repricing. The 137% gain shown in the snapshot is consistent with the "over 350% today" language in the headline, though the exact intraday peak may have been higher. No earnings, product, or operational news is present; the driver appears to be pure ownership concentration and market perception of who is now backing the stock.

STG

Sunlands Technology GroupConsumer Defensive

$6.10+$3.38

+124.3%

NYSE · Mkt cap $42 M

Sunlands Technology Group announced a $50 million share repurchase program and a material asset disposal for cash on May 29, likely driving the 124% gain by signaling capital return and operational restructuring.

The company released two announcements simultaneously on May 29 at 08:30 UTC: a $50 million share repurchase program and a material asset disposal transaction. Share buybacks are typically viewed positively by markets as they reduce share count, potentially supporting earnings per share and signaling management confidence in valuation. The asset disposal announcement suggests the company is generating liquidity, which combined with the buyback indicates active capital allocation. For a stock trading at $6.10 with apparent liquidity concerns in China's education sector, these dual announcements may have reassured investors about the company's cash position and commitment to shareholder returns. The magnitude of the gain is substantial, which could reflect either meaningful positive surprise or a reversal from prior pessimism, though the full details of the asset disposal were not provided in the news summaries.

PRFX

PRF Technologies Ltd.Healthcare

$3.00+$1.63

+119.0%

NASDAQ · Mkt cap $97 K

PRF Technologies announced advancement of its DeepSolar Predict AI platform toward commercial launch with focus on renewable energy forecasting, triggering a >250% premarket surge that carried into the regular session close at +119%.

The headline from May 28 details a concrete product milestone: PRF Technologies is advancing DeepSolar Predict, an AI forecasting platform for renewable energy markets, building on NVIDIA Connect participation and a weather-domain patent filing. The platform targets revenue optimization, forecasting accuracy, storage optimization and real-time market decision-making. This is a substantive development announcement rather than speculative news. The May 29 premarket headline explicitly notes shares were up over 250% following "the company upda[te]," confirming the May 28 announcement triggered the move. The +119% close suggests some volatility and profit-taking from the premarket peak, which is typical for gap-up moves in small-cap stocks. The stock's position as the 4 biggest gainer and the magnitude of the move indicate this was a material catalyst for investors focused on renewable energy AI solutions.

MYND

Mynd.ai, Inc.Consumer Defensive

$0.61+$0.33

+114.5%

AMEX · Mkt cap $20 M

Mynd.ai surged 114% after regaining NYSE American compliance by filing its overdue annual report on Form 20-F, resolving a listing violation that had likely weighed on the stock.

The company announced on May 29 that it successfully filed its Form 20-F annual report for fiscal year 2025, thereby regaining compliance with NYSE American filing requirements. This filing had apparently been delinquent, placing the company in violation status. The removal of a listing threat and the resolution of an administrative overhang are classic catalysts for sharp single-day reversals in micro-cap stocks, particularly those trading under two dollars where compliance risk is priced heavily. A secondary headline mentions Promethean, a brand owned by Mynd, showcasing products at InfoComm 2026, but this appears routine marketing activity rather than a material business development. The compliance restoration is the most plausible explanation for the magnitude of the move.

REPL

Replimune Group, Inc.Healthcare

$8.69+$4.01

+85.7%

OLOX

Olenox Industries Inc.Industrials

$8.77+$3.85

+78.3%

NASDAQ · Mkt cap $3.7 M

Olenox Industries announced completion of its acquisition of CS Digital Ventures on May 28, establishing a gas-powered data center platform targeting sub-$0.02/kWh power costs, directly addressing the AI and high-compute infrastructure boom and likely driving the 78% single-day gain.

On May 28, Olenox announced the closing of its acquisition of CS Digital Ventures, creating what management describes as a vertically integrated, U.S.-based, gas-powered platform for energy-intensive data centers and AI compute workloads with an emphasis on achieving power costs below $0.02 per kilowatt-hour. This is a strategically timed move in a sector experiencing explosive demand from generative AI infrastructure buildout. The headline establishes a completed material acquisition with operational specificity—named target, business rationale, and cost positioning—rather than speculative guidance. The market's 78% reaction suggests investors view the combined entity as well-positioned to capture margin-accretive, energy-intensive compute contracts. The timing relative to the May 29 announcement appearance in financial feeds aligns with market digestion of a May 28 close.

ASTC

Astrotech CorporationTechnology

$49.80+$20.37

+69.2%

NASDAQ · Mkt cap $16 M

Astrotech surged 69% today as part of a multi-day explosive rally exceeding 2,000% this week, driven by investor enthusiasm around its lunar infrastructure and Moon-based semiconductor manufacturing ambitions announced in recent headlines.

The headlines establish that ASTC has experienced extraordinary momentum over the past week, with premarket gains of 53% on May 28 following a 459% rise, and the stock is characterized as pursuing lunar-based advanced computing and semiconductor manufacturing opportunities. The May 29 headline explicitly frames this as the driver of "its best week on record." However, the news items provided do not reference a specific catalyst event—no dated announcement, contract award, partnership, funding round, or statement from management is identified. The surge appears to reflect investor speculation and enthusiasm around the company's long-term Moon infrastructure vision rather than a concrete near-term business milestone. This pattern is typical of micro-cap stocks with ambitious future-oriented narratives, which can trigger rapid momentum and retail interest absent traditional catalysts.

DLLL

GraniteShares 2x Long DELL Daily ETF

$199.51+$78.16

+64.4%

NASDAQ

No news headlines were found in the last 48 hours, but DLLL is a 2x leveraged ETF tracking Dell, so a sharp move in Dell stock would be mechanically amplified roughly twofold in this fund.

The absence of news headlines in the search results does not mean no catalyst occurred; it may simply reflect a lag in news aggregation or that the move happened intraday before headlines were published. However, DLLL's structure provides a clear explanation pathway: as a 2x daily leveraged long ETF on Dell, any significant rally in Dell shares would be magnified in DLLL's price. A 32% move in Dell would translate to roughly a 64% move in DLLL, which matches the observed gain. Without access to Dell's actual price action or breaking news about Dell (earnings, product announcements, strategic moves, activist involvement, or market conditions), we cannot pinpoint the specific trigger. The leverage structure itself, however, explains the amplification mechanism. To identify the root cause, one would need to check Dell's stock price movement and any news affecting the broader semiconductor or technology sector.

OKTG

Leverage Shares 2x Long OKTA Daily ETF

$24.66+$9.31

+60.7%

NASDAQ

No news headlines were published in the last 48 hours, but OKTG is a 2x leveraged long ETF tracking Okta (OKTA), so a +60.66% surge almost certainly reflects a major rally in the underlying stock itself, which would be amplified roughly 2x by the fund's structure.

The absence of recent news in the Yahoo Finance RSS feed means we cannot identify a specific catalyst from headline sources. However, OKTG is a daily leverage ETF that aims to deliver twice the daily return of its underlying asset, Okta Inc. A +60.66% move in the ETF is structurally consistent with a very large single-day move in OKTA itself, likely somewhere in the +25% to +35% range. This type of ETF responds mechanically to its underlying's performance and does not require company-specific news to move sharply; large market rotations, short squeezes, or undisclosed announcements in OKTA stock could all trigger such a move. Without headlines, the root cause remains unknown, but the magnitude of the ETF move is explained by its leverage and the underlying's apparent surge.

VCIG

VCI Global LimitedIndustrials

$8.47+$2.68

+46.3%

NASDAQ · Mkt cap $2.4 M

No news headlines were available in the last 48 hours for VCIG, so the 46% surge cannot be attributed to a specific announced event; the move likely reflects either delayed news pickup, technical trading, or rumor-driven activity.

The absence of any news in the Yahoo Finance RSS feed over the past two days makes it impossible to identify a concrete catalyst for the 46% gain. VCI Global Limited is a smaller-cap NASDAQ stock, and such securities are susceptible to several move drivers that may not generate immediate press coverage: short squeezes or covering, technical breakouts from support levels, social media attention, or delayed market reaction to company announcements made outside traditional news channels. Without access to the company's official filings, press releases, or trading halts, we cannot determine whether the move is fundamentally justified or speculative. The rank as the 11th biggest gainer suggests sector-wide strength is unlikely the sole cause, pointing instead to stock-specific activity.

CMND

Clearmind Medicine Inc.Healthcare

$3.58+$1.13

+46.1%

NASDAQ · Mkt cap $2.8 M

Clearmind Medicine announced a patent filing in Japan for its non-hallucinogenic psychedelic-based depression therapy, triggering a 46% stock surge likely driven by positive sentiment around IP expansion and therapeutic pipeline advancement.

On May 29, 2026, Clearmind Medicine disclosed that it filed a patent in Japan for its proprietary non-hallucinogenic psychedelic therapy targeting depression. The company is a clinical-stage biotech focused on novel psychedelic-based treatments. Patent filings in international markets, particularly from smaller biotech firms with early-stage assets, often generate enthusiasm among investors because they signal intellectual property protection, global market ambitions, and clinical progress. For a company of Clearmind's stage, establishing IP in a major jurisdiction like Japan can be interpreted as validation of the technology and expansion of competitive moat. The 46% single-day move suggests the market viewed this as material positive news, though the move is proportionally larger than typical for a routine patent filing, which may indicate either strong underlying interest in the psychedelic therapeutic space or lower daily trading liquidity amplifying price movement.

PRZO

ParaZero Technologies Ltd.Industrials

$0.93+$0.28

+42.5%

NASDAQ · Mkt cap $16 M

ParaZero announced expansion of full-scale production capacity for its DefendAir counter-drone systems on May 29, signaling growth and strengthened manufacturing capabilities, which likely drove the 42.48% intraday surge.

The headline released this morning confirms ParaZero has secured full-scale production capacity to meet growing demand for DefendAir, its counter-drone product family. This is a positive operational milestone that addresses a concrete business constraint—production bottleneck—and signals both market validation and management's confidence in revenue growth ahead. For a small-cap defense technology firm, demonstration of manufacturing scale-up and ability to fulfill orders is material to investor sentiment. The announcement directly supports demand narrative without requiring estimation of future performance. However, a 42% move in a single day on a capacity expansion alone is notable; the stock may have been oversold or there may be underlying momentum from broader defense sector interest that amplified the release's impact.

IOTR

iOThree Limited Ordinary SharesCommunication Services

$3.91+$1.11

+39.6%

NASDAQ · Mkt cap $13 M

No news headlines were found in the last 48 hours, so the 39.64% gain likely reflects a delayed reaction to an untracked announcement, technical reversal, or short-covering activity rather than a fresh public catalyst.

The absence of any news in Yahoo Finance's RSS feed over the past two days makes it difficult to attribute this substantial gain to a specific catalyst. iOThree is a small-cap technology company, and stocks in this category often experience sharp moves on limited volume driven by factors such as short-squeeze dynamics, technical chart breakouts, insider activity not yet widely reported, or delayed market reaction to company announcements made outside major news channels. Without access to the company's investor relations releases, SEC filings, or social media activity, the precise trigger cannot be identified. The timing and magnitude of a 39.64% one-day gain suggests either a binary event (contract award, funding announcement, partnership) or technical momentum, but neither can be confirmed from available evidence.

SPCE

Virgin Galactic Holdings, Inc.Industrials

$6.18+$1.65

+36.4%

NYSE · Mkt cap $487 M

Virgin Galactic surged 36% on a confluence of positive catalysts: resumption of flight testing, a derivative lawsuit settlement, Blue Origin's rocket explosion redirecting investor attention to competitors, and broader SpaceX IPO enthusiasm lifting the space sector.

The evidence shows multiple tailwinds converging on the same day. Virgin Galactic announced VSS Unity returned to flight testing on May 27 and a settled derivative lawsuit on May 28, both constructive developments for a company that has faced operational and legal challenges. Simultaneously, Blue Origin's New Glenn rocket explosion on May 29 appears to have shifted investor sentiment away from that competitor and toward alternative space plays, with SPCE gaining while AST SpaceMobile and Planet Labs fell sharply. Additionally, broader momentum in space stocks fueled by SpaceX IPO anticipation created a rising tide. The headlines also note retail investor interest in SPCE as the "only space tourism bet," suggesting retail enthusiasm contributed. The 36% single-day move reflects the compounding effect of these multiple positive narratives rather than any single dominant catalyst.

SPPL

SIMPPLE Ltd. Ordinary SharesIndustrials

$3.59+$0.94

+35.5%

NASDAQ · Mkt cap $22 M

No news headlines were found in the last 48 hours, so the 35% jump cannot be tied to any announced catalyst. The move likely reflects technical buying, short covering, or delayed market reaction to an earlier event.

SIMPPLE Ltd. (SPPL) surged 35.47% to rank among the day's top gainers, yet no recent news headlines are available to explain the move. This creates a gap between the magnitude of the price action and identifiable fundamental catalysts. For a micro-cap or small-cap stock trading on NASDAQ, such outsized single-day moves without concurrent news coverage can occur for several reasons. First, the move could reflect short covering or technical oversold conditions triggering a rally. Second, it could be a delayed market reaction to news that broke more than 48 hours ago but is only now being priced in. Third, it could stem from informal bullish commentary, social media momentum, or retail trading activity that does not always generate immediate press coverage. Without access to the specific business fundamentals, insider filings, or trading volume patterns for SPPL, it is not possible to pinpoint which of these mechanisms drove the move.

YMAT

J-Star Holding Co., Ltd. Ordinary SharesBasic Materials

$1.37+$0.35

+34.3%

NASDAQ · Mkt cap $7.3 M

No news headlines were found in the last 48 hours, so the 34.31% gain on YMAT stock cannot be attributed to a reported company announcement or market event. The jump likely reflects technical trading, a delayed news pickup, or unconfirmed market rumors.

YMAT posted the 17th largest single-day gain on NASDAQ with no recent news coverage in the provided sources. This disconnect suggests the move was not driven by a major announced catalyst such as earnings, guidance, partnerships, or regulatory approvals. For a small-cap or micro-cap stock trading at $1.37, sharp moves without immediate news coverage often reflect several possibilities: technical trading and short covering in a thinly traded security, delayed market reaction to older news not captured in the 48-hour window, unverified social media or message board activity, or sector-wide momentum. Without access to trading volume, short interest, or borrow data, we cannot determine whether this was a short squeeze or purely technical. The absence of headline coverage makes this move difficult to ground in fundamental fact.

PagerDuty, Inc.Technology

$9.93+$2.49

+33.5%

NYSE · Mkt cap $1.1 B

PagerDuty beat Q1 earnings and revenue expectations, announced a new CEO and a shift to usage-based pricing with AI tailwinds, and executed a significant share buyback, driving the 33% gain.

PagerDuty reported Q1 fiscal 2027 results on May 28 that exceeded both earnings and revenue estimates by 33.33% and 1.50% respectively, with revenue of $121 million. While sales were flat year-on-year, the market responded positively to three catalysts: first, the earnings beat itself; second, management's strategic pivot toward usage-based pricing and AI-driven growth, which signals a modernization of the business model; and third, according to the May 29 headline, a substantial share repurchase program that reduces share count and typically signals management confidence in valuation. The installation of a new CEO with prior experience at public and private software firms also appears to have restored investor confidence. The combination of beat guidance, strategic repositioning, and capital return through buybacks lifted the stock from an initial 14.7% pop on earnings to the final 33.47% gain.

DELL

Dell Technologies Inc.Technology

$421.30+$104.25

+32.9%

NYSE · Mkt cap $374 B

Dell's stellar first-quarter earnings results and strong AI server demand drove a 33% surge, triggering a broader rally in the infrastructure and semiconductor sector as investors repositioned into AI infrastructure winners.

The headlines establish that Dell released first-quarter earnings on May 29 that exceeded expectations, with particular strength in AI-fueled server demand. Multiple sources confirm this catalyzed a sector-wide rally: Hewlett Packard Enterprise surged, Super Micro Computer jumped on an AI cloud partnership win, and IBM benefited from positive read-through despite its own separate quantum computing announcement. The move appears driven by Dell's demonstrated ability to capitalize on the AI infrastructure buildout cycle, combined with investor rotation into server and data center hardware makers at a time when AI capex remains a dominant market narrative. The 33% single-day jump is unusually large even for a strong earnings beat, suggesting potential options-related dynamics or short covering alongside genuine fundamental repricing, though the headlines do not specify these mechanics.

GITS

Global Interactive Technologies, Inc.Communication Services

$2.13+$0.51

+31.5%

NASDAQ · Mkt cap $6.2 M

No news headlines were found in the last 48 hours for GITS, so the 31.48% gain cannot be attributed to a documented corporate announcement or event. The spike likely stems from technical trading, short covering, or an undisclosed rumor.

The absence of any Yahoo Finance headlines in the past 48 hours makes it impossible to tie this significant one-day gain to a specific catalyst such as earnings, product announcements, regulatory approvals, or strategic partnerships. For a micro-cap stock trading at $2.13, such moves are not uncommon and typically fall into a few categories: short squeeze activity (if the stock has high short interest), technical breakouts or momentum reversals driven by chart patterns, retail trading interest on social media, or market-moving news that has not yet been indexed by major financial RSS feeds. Without access to the stock's short interest ratio, trading volume history, or insider trading activity, we cannot definitively determine which mechanism drove today's gain.

Versus Systems Inc.Technology

$1.48+$0.35

+31.0%

NASDAQ · Mkt cap $8.3 M

No news headlines were found in the last 48 hours for Versus Systems, so the 31% gain on May 29 cannot be attributed to a specific announced event; the move likely reflects technical trading, delayed news pickup, or market speculation in a low-priced stock.

Versus Systems is a micro-cap gaming and esports technology company, and the absence of recent news headlines is notable given the magnitude of the gain. Low-priced stocks in speculative sectors are prone to outsized percentage moves on relatively light volume driven by technical factors, short covering, or sentiment shifts rather than fundamental news. The stock's rank as the 21st biggest gainer despite no identifiable catalyst suggests either a delayed market reaction to older news not captured in the 48-hour window, retail buying interest in a beaten-down name, or possible short-squeeze dynamics. Without access to intraday volume data or social media chatter, we cannot definitively identify whether this is momentum-driven, short-related, or tied to an unindexed company announcement.

OKTA

Okta, Inc.Technology

$123.27+$28.55

+30.1%

NASDAQ · Mkt cap $36 B

Okta delivered a first-quarter earnings beat with revenue topping expectations and raised full-year guidance, while analysts highlighted accelerating demand for its AI-powered identity security products as a key driver of future growth.

The headlines establish a clear and consistent narrative. Okta reported Q1 results that exceeded consensus estimates on both revenue and earnings, with revenue rising 11% year-over-year driven by subscription growth and higher contracted backlog. The company also raised its full-year outlook. Multiple sources emphasize that analyst attention has shifted beyond the earnings beat itself to the company's AI product pipeline and accelerating demand for AI-driven identity solutions. Brokerage firms issued bullish calls with revised price targets clustered around $120, close to or below the current price of $123.27. The 30% single-day gain appears disproportionate to a typical earnings beat, suggesting the market may be repricing the stock based on revised long-term growth expectations tied to AI adoption in cybersecurity, particularly in identity management. The broader market rally on Iran peace hopes and AI spending momentum may have also provided tailwinds.

Magnachip Semiconductor CorporationTechnology

$8.80+$2.01

+29.6%

NYSE · Mkt cap $122 M

Magnachip announced it will showcase Medium-Voltage MOSFET solutions for AI server and data center applications, positioning itself in the high-growth AI infrastructure market and driving investor optimism about its product portfolio relevance.

The headline indicates that Magnachip is actively promoting Medium-Voltage MOSFET technology designed specifically for server power supplies, high-performance computing, and industrial systems. This announcement appears timed to capitalize on investor appetite for semiconductor exposure to AI infrastructure buildout. The 29% single-day gain suggests the market viewed this product showcase favorably, likely interpreting it as evidence that the company has competitive solutions for the booming data center power management segment. However, the news does not include specific customer wins, revenue guidance updates, or quantified addressable market claims. The gain may also reflect broader sector momentum in AI-adjacent semiconductors or the stock finding technical support at a key level. The headline itself is promotional in tone rather than announcing concrete business results, which leaves some room for interpretation about whether this is a major inflection point or incremental positive positioning.

NOWL

GraniteShares 2x Long NOW Daily ETF

$7.30+$1.63

+28.7%

NASDAQ

No news headlines were found in the last 48 hours, but NOWL is a 2x leveraged long ETF on ServiceNow stock, so a strong rally in NOW would mechanically amplify to roughly double the percentage gain, making a ~28.75% jump consistent with NOW gaining approximately 14-15% on positive catalyst or bro…

The absence of breaking news in the provided headlines does not mean no catalyst exists; it may simply mean the news had not yet propagated to Yahoo Finance's RSS feed by the snapshot date, or the move occurred on intraday momentum. NOWL is a daily reset leveraged ETF designed to deliver roughly 2x the daily return of the underlying ServiceNow (NOW) stock. A +28.75% move in NOWL is mathematically consistent with approximately a +14% move in NOW. This level of equity ETF movement typically reflects either strong earnings or guidance, analyst upgrades, major contract wins, or broad sector momentum in enterprise software or cloud computing. Without specific headlines confirming the driver, the most likely categories are: (1) a NOW earnings or guidance beat released within the window, (2) positive ServiceNow-specific news (new product, customer win), or (3) broad tech sector rally that lifted enterprise software stocks. The leveraged structure of NOWL guarantees it will magnify whatever move its underlying asset made.

ADVB

Advanced Biomed Inc. Common StockHealthcare

$5.01+$1.10

+28.1%

NASDAQ · Mkt cap $14 M

No news headlines were available in the last 48 hours to explain ADVB's 28% gain on May 29, 2026. The jump likely stems from a delayed earnings release, clinical trial result, FDA action, or other corporate announcement not yet captured in the RSS feed.

Advanced Biomed is a biotech/medical device company where a single-day 28% jump typically reflects a material positive catalyst. The absence of headlines in the Yahoo Finance RSS feed in the last 48 hours does not mean no news occurred; timing delays between wire releases, regulatory filings, and RSS aggregation are common. Biotech stocks commonly move sharply on clinical trial outcomes, FDA approvals or clearances, earnings beats with raised guidance, partnership announcements, or insider buying activity. The magnitude of the move (top 25 gainer) suggests something more substantive than technical trading or sentiment shifts alone, but without confirmed headlines the specific driver remains unknown. It is also possible the news broke late on May 29 and has not yet propagated to the RSS feed used here.

YXT

Yxt.Com Group Holding LtdTechnology

$0.55+$0.12

+27.6%

NASDAQ · Mkt cap $19 M

No headlines were found in the last 48 hours, so the 27.56% gain on May 29 cannot be directly attributed to a specific news catalyst based on available evidence.

YXT experienced a sharp intraday rally of over 27 percent on May 29, 2026, but no corresponding news headlines from Yahoo Finance appear in the provided 48-hour window. This disconnect is notable. For a microcap or thinly-traded stock like YXT trading near $0.55, large single-day moves can be driven by several non-news factors: short covering or low short-float mechanics, delayed announcement disclosure, social media-driven retail momentum, technical chart breakouts, or broad market tailwinds affecting the sector. Without contemporaneous headlines or visibility into volume, short interest, or technical setup, the specific catalyst remains opaque. The move could reflect news that has not yet been indexed by the feed used here, or it could be a technical or sentiment-driven event with no formal news catalyst at all.

ZETX

Daily Target 2X Long ZETA ETF

$26.70+$5.69

+27.1%

AMEX

No news headlines were published in the last 48 hours. ZETX is a 2X leveraged long ETF tracking ZETA, so its 27% gain likely reflects a sharp move in the underlying ZETA index or ETF, amplified by the 2X leverage structure.

No recent news was found to explain the move, which presents a challenge since ZETX is a derivative instrument whose price depends entirely on its underlying asset (ZETA) and leverage mechanics. A 27% single-day gain on a 2X leveraged ETF implies the underlying ZETA moved roughly 13-14%, which is a significant intraday move. This kind of large percentage gain in a leveraged ETF typically stems from three categories: a major announcement or earnings beat in the underlying holdings, technical or short-squeeze buying pressure, or delayed market reaction to news that broke outside the captured 48-hour window. Without visibility into ZETA's composition or recent price action, we cannot pinpoint which factor drove the move. Leveraged ETFs are also sensitive to intraday volatility and can experience outsized tracking effects on highly volatile days.

CHA

Chagee Holdings Limited American Depositary SharesConsumer Defensive

$12.76+$2.60

+25.6%

MBSX

Regan Fixed Rate MBS ETF

$35.00+$7.00

+25.0%

AMEX

No news headlines were found in the last 48 hours, so the 25% surge in MBSX likely reflects either a sharp rally in the underlying fixed-rate mortgage-backed securities market (possibly driven by falling interest rates) or a technical/liquidity event specific to this ETF.

The absence of any recent news makes a direct attribution impossible. However, MBSX is a fixed-rate mortgage-backed securities ETF, which means its price is highly sensitive to interest rate movements. A significant drop in Treasury yields or longer-duration rates would mechanically push up MBS values and the ETF's NAV. Such a move could occur on macro data (weaker economic indicators, Fed signaling, inflation data) or broader market technicals. Alternatively, the 25% jump could reflect a liquidity squeeze, rebalancing event, or delayed reporting of an older catalyst. Without corroborating headlines, the most probable category is a sudden shift in rate expectations or market conditions affecting the MBS asset class broadly.

MYSZ

My Size, Inc.Consumer Cyclical

$0.62+$0.12

+24.5%

NASDAQ · Mkt cap $1.7 M

No news headlines were available in the last 48 hours to explain MYSZ's 24.55% gain, so the catalyst remains unclear from the public record provided.

My Size Inc. jumped 24.55% to $0.62 on May 29, 2026, but Yahoo Finance reported no headlines in the preceding 48 hours. This absence of identifiable news is typical for micro-cap or penny stocks, which often trade on limited liquidity and can experience sharp moves on minimal volume without accompanying disclosure. The most likely categories of cause are technical or momentum-driven (e.g., short covering, algorithmic buying, or a delayed market reaction to an earlier announcement not in this feed), a company filing released directly rather than picked up by major news outlets, or speculation driven by social media or message boards. Without access to SEC filings, insider activity, or full newswire coverage beyond Yahoo's RSS, pinpointing the specific catalyst is impossible.

CREG

Smart Powerr Corp.Utilities

$0.29+$0.06

+23.9%

NASDAQ · Mkt cap $499 K

No news headlines were found in the last 48 hours, so the 23.94% gain likely reflects technical trading activity, delayed market reaction to older news, or speculative interest in this micro-cap stock rather than a fresh catalyst.

Smart Powerr Corp. is a micro-cap NASDAQ-listed security, and the absence of recent headlines combined with a significant single-day gain is not uncommon in this category. Stocks in this range often experience large percentage moves on relatively modest absolute volume, driven by technical factors such as short covering, options-related hedging adjustments, or retail trading activity rather than fundamental news. The stock may also be responding to an announcement or event that has not yet surfaced in the Yahoo Finance RSS feed, or the move could reflect accumulated market interest from earlier in the week. Without supporting news or disclosure, attributing the move to any specific business development would be speculation.

SCLX

Scilex Holding CompanyHealthcare

$8.90+$1.69

+23.4%

NASDAQ · Mkt cap $40 M

No news headlines were found in the last 48 hours for SCLX, so the 23.44% gain likely reflects a delayed market reaction to an earlier announcement, technical trading, or an untracked catalyst such as an earnings release or corporate development.

The absence of recent headlines despite a substantial single-day gain of nearly 24% makes it difficult to pinpoint a specific catalyst with certainty. For a smaller-cap biotech or specialty pharma company like Scilex, typical drivers of this magnitude include clinical trial results, FDA approvals or guidance, partnership announcements, earnings surprises, or short-covering rallies. The timing mismatch between the price action and available news suggests either that the news broke outside the Yahoo Finance RSS feed monitored here, the market is reacting to an announcement from earlier in the week that is no longer being actively syndicated, or there is a non-news technical or sentiment-driven catalyst at play. Without access to the actual headline or corporate filings from the relevant date, the cause remains speculative.

SMCX

Daily Target 2X Long SMCI ETFFinancial Services

$29.31+$5.50

+23.1%

APM

Aptorum Group LimitedHealthcare

$1.03+$0.19

+22.9%

NASDAQ · Mkt cap $6.6 M

No headlines were found in the last 48 hours for APM, so the 22.90% jump cannot be attributed to announced news. The move may reflect technical trading, delayed news pickup, or market rumors about a small-cap biotech firm.

Aptorum Group Limited is a small-cap biotechnology company, and the absence of any news headlines in the past 48 hours means we cannot link today's sharp gain to a specific catalyst like clinical trial results, regulatory approval, partnership, or earnings. For stocks in this sector and market cap range, large single-day moves often reflect thin liquidity, short covering, technical chart breaks, or market chatter not yet captured in major news feeds. Without access to regulatory filings, pre-market disclosures, social media activity, or news wires narrower than Yahoo Finance, we cannot identify the precise trigger. The move may also be a delayed reaction to an announcement made before the 48-hour window or a rumor circulating in retail or institutional circles.

UPC

Universe Pharmaceuticals Inc.Healthcare

$3.50+$0.65

+22.8%

NASDAQ · Mkt cap $3.5 M

No news headlines were found in the last 48 hours, so the 22.81% gain on UPC likely stems from a delayed announcement, technical rebound, small-cap volatility, or undisclosed company development.

There are no recent headlines provided to explain Universe Pharmaceuticals' sharp 22.81% intraday gain. For small-cap biotech and pharmaceutical stocks like UPC, large single-day moves often occur in response to clinical trial results, FDA decisions, capital raises, or partnership announcements that may appear on company websites or press wires before reaching major financial news aggregators. Another common driver is short-covering or algorithmic rebalancing in thinly traded names. Without access to real-time company filings, SEC announcements, or specialized biotech news services, it is not possible to identify the specific catalyst. The magnitude of the move suggests something material occurred, but the cause remains unknown based on the information available here.

HOOX

Daily Target 2X Long HOOD ETFFinancial Services

$31.90+$5.89

+22.6%

HODU

Direxion Daily HOOD Bull 2X ETF

$11.60+$2.14

+22.6%

NASDAQ

No news headlines were found in the last 48 hours, but HODU is a 2X leveraged bull ETF tracking Robinhood Markets (HOOD), so a ~11% daily move in the underlying stock would amplify to approximately this 22% gain through mechanical leverage.

Zero news headlines appeared in the search results covering the 48 hours before this snapshot. HODU is a daily reset leveraged ETF designed to deliver 2X the daily performance of HOOD. This means that if the underlying Robinhood Markets stock gained approximately 11% on May 29, 2026, the ETF would mechanically deliver roughly double that return through its leverage structure. Without access to news about HOOD itself or the broader market on that date, we cannot identify the specific catalyst driving the underlying stock higher. The move could stem from earnings, analyst upgrades, sector rotation, short covering, or other market events affecting Robinhood, but the evidence provided does not specify which. The magnitude of the gain is consistent with what such a leveraged instrument would produce in response to a meaningful underlying move.

NTAP

NetApp, Inc.Technology

$174.29+$31.89

+22.4%

NTCL

NetClass Technology IncTechnology

$0.99+$0.18

+22.3%

NASDAQ · Mkt cap $3.3 M

No news headlines were found in the last 48 hours for NTCL, so the 22.34% intraday gain likely reflects technical trading activity, small-cap volatility, or unreported developments not yet indexed by Yahoo Finance.

The absence of any recent news headlines makes it difficult to attribute this move to a specific corporate event such as earnings, guidance revision, regulatory approval, or partnership announcement. NTCL is a micro-cap stock trading at $0.99, a price point where liquidity is typically thin and share counts can be high, making intraday moves more susceptible to momentum trading, options activity, or short covering. Penny stocks and stocks near single-digit price levels are often subject to elevated volatility driven by technical factors, retail trading concentration, or delayed news dissemination. It is also possible that a material announcement was made but has not yet propagated through major financial news aggregators, or that the move reflects intraday technical strength unrelated to news. Without verifiable headlines or structural insight into NTCL's capital structure or short interest, the true catalyst remains unclear.

HOOG

Leverage Shares 2x Long HOOD Daily ETF

$28.15+$5.12

+22.2%

INDP

Indaptus Therapeutics, Inc.Healthcare

$1.76+$0.32

+22.2%

NASDAQ · Mkt cap $125 M

No news headlines were found in the last 48 hours, so the 22% gain on INDP likely reflects a delayed market reaction to an earlier announcement, technical rebound, or sector-wide momentum that isn't captured in the available news feed.

The absence of any news in the last 48 hours makes direct causation impossible to establish from the provided evidence. Indaptus Therapeutics is a small-cap biotech company, and stocks in this category are particularly prone to volatility driven by several common catalysts: delayed market pricing of older announcements (clinical trial results, FDA feedback, partnership news), short covering or technical bounces off support levels, sector rotation into biotechnology, or rumors not yet covered in major news outlets. Without headlines tied to earnings, regulatory decisions, or material developments, the 22% single-day jump falls into the category of moves that require investigation beyond the available snapshot.

ABTS

Abits Group Inc.Financial Services

$0.99+$0.18

+21.8%

NASDAQ · Mkt cap $4.1 M

No news was found in the last 48 hours, so the 21.79% gain is unexplained by disclosed information; the move likely reflects technical momentum, delayed reporting of a company announcement, or retail speculation common in sub-$1 micro-cap stocks.

Yahoo Finance shows zero headlines for ABTS in the past 48 hours despite a significant single-day rally that placed it among the top 42 gainers on NASDAQ. This absence of news coverage is noteworthy and suggests either the catalyst has not yet been reported by major financial media, or the move is driven by non-news factors. Micro-cap stocks trading under $1 are historically susceptible to technical bounces after heavy selling, short-squeeze dynamics if short interest is elevated, or retail investor coordination on social platforms that precedes formal news dissemination. Without access to after-hours press releases, SEC filings, or social media sentiment, we cannot identify the specific catalyst. The timing gap between price action and news availability is common but leaves attribution unclear.

TSSI

TSS, Inc.Technology

$16.48+$2.94

+21.7%

NASDAQ · Mkt cap $266 M

No material news about TSSI itself was provided; the only mention is a comparison article noting how TSSI and LGIH performed relative to construction peers, which does not explain a sharp 21.71% single-day jump.

The lone headline references a sector comparison article between LGI Homes and TSS Inc., but contains no announcement, earnings report, product news, or corporate action tied to TSSI. A comparison article alone rarely drives a 21.71% move. Possible explanations include: first, a delayed market reaction to an earlier announcement not captured in this 48-hour window; second, short-squeeze dynamics if TSSI has high short interest or low float; third, technical breakout or options-expiration related activity; fourth, an undisclosed rumor or social-media catalyst not reflected in formal news. Without headlines directly tied to the stock's fundamentals or forward guidance, the cause remains unclear, though construction-related stocks can be sensitive to housing data, interest-rate expectations, or sector rotation.

ORCX

Daily Target 2X Long ORCL ETFFinancial Services

$58.45+$10.40

+21.6%

ORCU

Direxion Daily ORCL Bull 2X ETF

$20.99+$3.72

+21.5%

NASDAQ

No news headlines were published in the last 48 hours, but ORCU is a 2X leveraged bull ETF on Oracle, so a strong move in ORACLE stock itself would be mechanically amplified roughly twofold in this fund.

The absence of news in the RSS feed makes it impossible to identify a specific catalyst. However, ORCU's structure as a daily leveraged ETF tracking Oracle with 2X bull exposure means the underlying 21.54% surge likely corresponds to a roughly 10-11% gain in Oracle stock itself. This kind of move would typically be driven by significant company news such as earnings results that substantially beat expectations, positive guidance revisions, major contract announcements, strategic acquisitions, or broad market rallies in technology. Without access to Oracle-specific headlines from the past 48 hours, we cannot pinpoint which of these drove the move, only that the amplified nature of this ETF product means it captures and magnifies whatever catalyst moved the underlying equity. The gap between the headline feed and the price action suggests either a delayed RSS update or that the Oracle news appeared outside the sampled news sources.

EEIQ

Elite Education Group International LimitedConsumer Defensive

$3.22+$0.57

+21.5%

NASDAQ · Mkt cap $4.6 M

No news headlines were available in the last 48 hours to explain EEIQ's 21.51% gain, so the catalyst remains unclear from public disclosures during this period.

The absence of any news in the Yahoo Finance RSS feed over the last two days means we cannot anchor the move to a specific corporate event, earnings release, regulatory action, or strategic announcement. For a microcap education stock like EEIQ, such sharp single-day moves can sometimes reflect technical factors (short covering, options positioning, or thin-float volatility), delayed news that has not yet been widely indexed, or market rumors not yet formalized in official channels. Without access to company filings, insider trading alerts, or other real-time sources beyond the provided headlines, it is honest to say the specific catalyst is unknown at this snapshot date.

HLP

Hongli Group Inc.Basic Materials

$0.61+$0.11

+21.5%

NASDAQ · Mkt cap $90 M

Hongli Group announced engagement of battery technology expert Dr. Phillip A. Medina IV as an independent technical advisor for energy storage initiatives, signaling potential strategic pivot or expansion that drove a 21.48% gain on modest trading.

The headline reveals a structural shift in Hongli Group's business positioning. Historically known as a cold rolled steel profile manufacturer, the company's announcement of a dedicated technical advisor for energy storage and battery technology represents a material strategic expansion into higher-growth adjacent markets. This type of appointment often signals management's intent to develop new revenue streams or pivot toward sectors with stronger growth narratives and investor appetite. For a micro-cap stock like HLP trading at $0.61, such strategic repositioning announcements can trigger outsized percentage moves, particularly if accompanied by retail or momentum-driven buying. However, the headline provides minimal detail on the scope, timeline, or commercial viability of these energy storage initiatives, leaving substantial uncertainty about whether this represents a meaningful business development or primarily a rebranding effort.

CXAI

CXApp Inc.Technology

$0.21+$0.04

+21.4%

NASDAQ · Mkt cap $10 M

No news headlines were found in the last 48 hours, so the 21.4% gain appears driven by factors other than major corporate announcements, likely technical trading, market sentiment, or untracked social/retail interest.

The absence of recent news headlines on a stock jumping to the 48th biggest gainer of the day is notable and suggests the catalyst is not a traditional corporate event like earnings, guidance, FDA approval, or M&A. For a low-priced stock like CXAI trading at $0.21, the most common drivers of such moves in the absence of news are technical factors such as short covering, momentum-driven retail interest, or accumulated positive sentiment from earlier announcements not yet reflected in current price. The gain could also reflect delayed market reaction to older news, discussions on social platforms, or algorithmically-driven trading. Without access to the company's fundamentals, recent earnings history, or short interest data, pinpointing the specific cause remains speculative.

SNSE

Sensei Biotherapeutics, Inc.Healthcare

$21.14+$3.55

+20.2%

NASDAQ · Mkt cap $44 M

No news headlines were found in the last 48 hours, so the 20% gain in SNSE on May 29, 2026 cannot be attributed to a specific announced event; the move likely reflects either delayed market reaction to an earlier announcement, technical/short-squeeze activity, or undisclosed company developments.

Sensei Biotherapeutics is a clinical-stage immunotherapy company, and a 20% single-day gain of this magnitude in a biotech stock typically correlates with material catalysts such as clinical trial results, regulatory decisions, partnership announcements, or significant financing events. The absence of any headline in the provided 48-hour window means either the triggering news fell outside that timeframe, occurred via non-traditional channels, or the move was driven by technical factors (covering short positions, options expiration effects, or market sentiment shifts). For a small-cap biotech, short squeezes and momentum trading can also drive outsized daily moves independent of fundamental news. Without corroborating information, we cannot definitively link this gain to company-specific positive developments versus market mechanics or sentiment.

IMRN

Immuron LimitedHealthcare

$1.45+$0.24

+19.8%

NASDAQ · Mkt cap $9.6 M

No news headlines were found in the last 48 hours, so the 19.83% gain appears driven by technical factors, market rumors, or delayed announcements not yet captured in the news feed.

The absence of any recent headlines for Immuron Limited makes it difficult to pinpoint a specific fundamental catalyst for today's 19.83% jump. Immuron is a small-cap biotech/immunology company, and such stocks can exhibit sharp moves on light volume when sentiment shifts, technical breakouts occur, or unconfirmed rumors circulate. Possible explanations include a clinical trial update or regulatory filing that has not yet reached major news wires, insider buying or analyst initiation, a short squeeze on a thinly traded security, or simply algorithmic or retail momentum in a micro-cap name. Without corroborating headline evidence, the underlying cause remains speculative.

Biggest Losers

Fri, May 29, 2026 49

POAS

Phaos Technology Holdings (CaymHealthcare

$0.52−$2.15

-80.5%

AMEX · Mkt cap $5.2 M

No news headlines were found in the last 48 hours, so the 80% single-day collapse of POAS likely stems from a market announcement, corporate action, or technical event that has not yet been indexed by major financial news feeds.

The complete absence of recent headlines despite an extraordinary single-day loss of 80% is unusual and suggests either a delayed news indexing lag, an after-hours corporate announcement, or a material corporate event that Yahoo Finance RSS has not yet captured. For micro-cap stocks trading on exchanges like AMEX, common catalysts for such severe declines include reverse stock splits, dilutive financing announcements, delisting warnings, failed clinical or regulatory milestones, or shareholder litigation disclosures. Without access to the company's investor relations channels, SEC filings, or real-time news wires, pinpointing the specific cause is not possible from the evidence at hand. The stock's low price of $0.52 and AMEX listing suggest it is a higher-risk, lower-liquidity security where information dissemination can lag retail-focused news aggregators by hours.

ZCMD

Zhongchao Inc.Healthcare

$0.17−$0.37

-69.1%

NASDAQ · Mkt cap $6.2 M

Zhongchao announced a $5 million best-efforts public offering on the day of the 69% drop, a dilutive capital raise that typically triggers sharp selloffs in small-cap stocks due to shareholder dilution and signaling concerns.

The company announced pricing of a $5 million best-efforts public offering on 2026-05-29, the same day of the massive 69% decline. Best-efforts offerings are generally viewed negatively by markets because they signal financial distress (the company needs cash urgently), carry higher execution risk (not all shares may sell), and dilute existing shareholders. For a micro-cap stock trading at $0.17, a $5 million offering represents material dilution. The timing of the announcement with the price collapse is consistent with investor capitulation upon learning of the raise. The news headline confirms the event occurred and is directly relevant to equity value, making this a clear case of announcement-driven selling.

NCPL

Netcapital Inc.Financial Services

$1.10−$0.69

-38.5%

NASDAQ · Mkt cap $1.8 M

Netcapital announced an AI-focused asset acquisition on May 28, but the headline snippet is incomplete, preventing clear identification of whether the deal terms, financing structure, or market sentiment about the acquisition triggered the 38.55% collapse.

The only news provided is a truncated announcement of an asset acquisition related to AI strategy, dated May 28, 2026, with a conference call at 4:30 pm ET on that same day. The headline text cuts off mid-sentence, so critical details are missing: the acquisition price, how it will be funded, dilution to shareholders, earnout terms, or management commentary during the call. A stock dropping 38.55% on an acquisition announcement typically signals either unfavorable deal economics (overpayment, excessive dilution), disappointing guidance delivered during the call, or negative Q&A responses from analysts. Without the full text of the announcement or call transcript, it is impossible to isolate which element drove the loss. The timing—announcement and call on the 28th, price collapse reflected on the 29th—is consistent with investors reacting to specific disclosed terms or management commentary.

CNEY

CN Energy Group. Inc.Basic Materials

$1.00−$0.61

-37.9%

NASDAQ · Mkt cap $5.0 M

No news headlines were available in the last 48 hours, so the 37.89% drop cannot be directly attributed to a disclosed event. The decline likely reflects a negative catalyst not yet captured in public headlines, such as an unannounced earnings miss, insider selling, or sector-wide pressure.

Despite CNEY's severe single-day loss ranking it as the fourth biggest loser on NASDAQ, no news articles appeared in the Yahoo Finance RSS feed during the relevant period. This absence is notable given the magnitude of the decline. For a micro-cap or thinly traded stock like CNEY, such sharp moves can occur from several sources: delayed disclosure of earnings or guidance, a regulatory filing or delisting notice, sudden insider transactions, short-squeeze reversal after a prior rally, or sector-wide contagion in energy stocks. Without confirmed headlines, we cannot determine which factor applies here. The gap between price action and news availability suggests either the catalyst predates the headline window, the market moved on unconfirmed information or rumors, or a delayed filing effect is in play.

SNBR

Sleep Number CorporationConsumer Cyclical

$1.19−$0.63

-34.6%

NASDAQ · Mkt cap $611 K

No news headlines were found in the last 48 hours to explain Sleep Number's 34.62% single-day collapse, making the cause unclear without access to broader market data or intraday events.

The absence of any news in the Yahoo Finance RSS feed over the past two days creates a significant gap in explaining a stock in the top five biggest losers. For a mature consumer discretionary company like Sleep Number, such a severe single-day drop typically correlates with earnings misses, margin compression warnings, same-store sales declines, analyst downgrades, or broader sector selloffs in furniture and bedding. It is also possible that negative news broke outside the RSS feed window, market sentiment shifted on macroeconomic concerns affecting discretionary spending, or there was an institutional exit or technical breakdown. Without contemporaneous headlines or market-wide context, attributing causation is speculative rather than evidence-based.

SUGP

SU Group Holdings Limited Ordinary SharesIndustrials

$1.02−$0.47

-31.5%

NASDAQ · Mkt cap $6.9 M

A positive regulatory approval announcement from SU Group's subsidiary Fortune Jet on 2026-05-28 does not align with the -31.54% collapse in share price on 2026-05-29, suggesting the headline news is unrelated to the dramatic sell-off and an undisclosed negative catalyst likely drove the move.

The only headline available describes Fortune Jet becoming the first company in Hong Kong approved to deliver QASRS Security Training in multiple languages. This is a positive regulatory milestone that would typically support or maintain stock value, not trigger a near-32% collapse. The timing mismatch (announcement 2026-05-28, stock crash 2026-05-29) combined with the favorable nature of the news suggests the price action was driven by an undisclosed event. For a micro-cap security services company like SUGP, common catalysts for this magnitude of decline include missed earnings or guidance, sudden insider selling, delisting warnings, debt covenant breaches, loss of major contracts, or adverse regulatory findings unrelated to the Fortune Jet announcement. Without access to additional corporate filings, earnings releases, or market reports from 2026-05-29, the specific trigger remains unknown.

ADTX

Aditxt, Inc.Healthcare

$0.12−$0.05

-28.5%

NASDAQ · Mkt cap $2.3 M

No news headlines appeared in the last 48 hours for ADTX, so the 28.54% drop cannot be attributed to a specific disclosed event; the cause remains unknown without additional reporting.

Aditxt experienced a sharp single-day decline of nearly 29% with no corresponding news coverage in the Yahoo Finance RSS feed over the prior two days. This disconnect suggests either that the catalyst occurred outside the captured news window, was announced through a non-standard channel (company press release, SEC filing, social media), or reflects technical/market-driven selling in a low-liquidity micro-cap stock. Biotech and healthcare IT firms like ADTX are sensitive to clinical trial results, regulatory decisions, financing announcements, and changes in cash runway or partnerships. Without access to SEC filings or direct company communications from the snapshot date, the specific trigger cannot be identified. The lack of headline coverage does not rule out material news but simply means it was not captured in this RSS feed.

CGTL

Creative Global Technology Holdings Limited Ordinary SharesConsumer Cyclical

$0.50−$0.20

-28.5%

NASDAQ · Mkt cap $8.2 M

No news headlines were found in the last 48 hours, so the 28.46% drop on CGTL cannot be attributed to a specific announced event; the cause likely lies in technical selling, market sentiment, or undisclosed material information.

The absence of any recent news headlines makes it impossible to identify a concrete catalyst for CGTL's sharp 28.46% decline. For a micro-cap or thinly traded NASDAQ stock trading at $0.50, such sharp moves are sometimes driven by technical factors including stop-loss cascades, options expiration mechanics, or shifts in retail sentiment on social media platforms. Alternatively, material information may have circulated through private channels, analyst downgrades, or informal networks before reaching mainstream financial news aggregators. Without access to SEC filings, insider trading activity, or real-time trading data, attributing this move to any specific cause would be speculation.

NCT

Intercont (Cayman) Limited Ordinary sharesIndustrials

$2.79−$1.09

-28.1%

NASDAQ · Mkt cap $38 M

No news headlines are available for the last 48 hours to explain the 28% drop in NCT stock, making the specific catalyst unknown.

Intercont (Cayman) Limited experienced a severe 28% single-day decline with no corresponding news coverage in the available sources. This absence of major headlines for a move of this magnitude is unusual. Several categories of catalyst are possible for a stock with this profile: the company could have reported disappointing earnings or guidance outside the captured news window; there may have been an unannounced corporate action such as a dilutive offering or insider selling; the move could reflect technical factors like forced liquidations in a thinly traded security; or there could be unconfirmed rumors affecting the stock. Without access to company filings, SEC documents, or investor communications, it is impossible to determine which of these explanations applies. The ticker's positioning as a Cayman Islands company and its relatively small market presence suggest it may receive limited news coverage, even for material events.

CUPR

Cuprina Holdings (Cayman) Limited Class A Ordinary SharesHealthcare

$2.40−$0.90

-27.3%

NASDAQ · Mkt cap $8.0 M

Cuprina announced completion of a reverse stock split and filed to maintain its Nasdaq listing, signaling serious compliance struggles that typically precede delisting and shareholder dilution, triggering the steep sell-off.

The headline reveals Cuprina has completed a reverse stock split and is now formally requesting a hearing before the Nasdaq Hearings Panel to maintain its listing status. A reverse split combined with an active delisting defense is a red flag for investors. Reverse splits are typically executed when a stock has fallen below Nasdaq's minimum bid price requirement (historically $1.00). The fact that management must now petition to stay listed—rather than having automatically resolved the issue via the split alone—suggests either the stock is still not compliant or other listing standards are in jeopardy. This situation creates material uncertainty about the company's ability to remain on the exchange and raises questions about operational viability. Investors typically exit positions facing delisting risk due to both the operational signal and the practical complications of holding stocks that move to OTC markets.

GIPR

Generation Income Properties, Inc.Real Estate

$0.21−$0.08

-26.8%

NASDAQ · Mkt cap $253 K

Generation Income Properties announced a $5 million public offering of 23.8 million shares on May 28, which typically causes dilution-driven selloffs in micro-cap stocks, explaining the 26.76% single-day drop.

The company announced pricing of a best-efforts public offering of approximately 23.8 million shares on May 28, 2026. For a micro-cap stock trading at $0.21, an offering of that magnitude represents significant dilution to existing shareholders. The math is stark: at $0.21 per share, 23.8 million shares would theoretically raise approximately $5 million, but the issuance itself dilutes ownership and typically triggers immediate selling pressure as investors fear further downward price movement post-offering. Best-efforts offerings carry additional uncertainty since they only close if minimum subscriptions are met, which can amplify concern. The timing of the announcement late on May 28 and the stock's decline on May 29 aligns directly with market absorption of dilution risk. This is a textbook reaction for thinly-traded, low-priced equities facing equity raises.

PIII

P3 Health Partners Inc.Healthcare

$12.18−$4.29

-26.0%

NASDAQ · Mkt cap $1.8 B

No news headlines were found in the last 48 hours, so the 26% drop cannot be directly attributed to a disclosed event. The decline likely stems from broader market pressure, earnings disappointment, sector rotation, or an undisclosed material development affecting the healthcare provider sector.

With no recent news headlines available to explain the sharp 26% sell-off, we cannot pinpoint a specific catalyst. P3 Health Partners is a physician-led healthcare services company, and stocks in this sector are sensitive to several dynamics including changes in Medicare reimbursement rates, operational performance misses, management turnover, competitive pressures, or shifts in healthcare policy. A drop of this magnitude typically reflects either a material earnings or guidance miss not yet captured in the RSS feed, a sector-wide sell-off affecting healthcare providers, or possibly news released after market close or through a channel not reflected in the headline snapshot. Without access to earnings releases, SEC filings, or company announcements from the relevant window, the specific cause remains unclear.

AKTX

Akari Therapeutics, PlcHealthcare

$16.43−$5.62

-25.5%

NASDAQ · Mkt cap $14 M

Despite the company announcing its first ASCO abstract acceptance and highlighting positive early data on AKTX-101, AKTX fell 25.49%, suggesting the market either viewed the news as insufficient or responded to unrelated sector or macro headwinds.

The headlines from May 28 describe what appear to be positive developments: Akari's first ASCO abstract acceptance and a CEO interview discussing the "breakthrough potential" of AKTX-101 combined with adagasrib in KRAS-driven cancers. However, these are typically investor relations and conference announcement items rather than pivotal trial readouts or regulatory milestones. The severity of the 25.49% drop on the day of or immediately after these announcements suggests either the market found the data underwhelming relative to expectations, or the move was driven by factors unrelated to the ASCO news such as sector rotation, a negative analyst action, short-covering reversal, or broad biotech weakness. One headline notes European equities were "trending slightly lower" on May 28, which could indicate modest sector headwinds. Without a specific negative catalyst named in the headlines, the true driver remains unclear.

AEMD

Aethlon Medical, Inc.Healthcare

$2.21−$0.73

-24.8%

NASDAQ · Mkt cap $1.5 M

No news headlines were found in the last 48 hours, so the 24.83% drop cannot be directly attributed to a published announcement. The decline likely stems from a market-wide move, technical breakdown, or untracked news event.

Aethlon Medical is a small-cap biomedical device company with limited trading liquidity, which means its stock is prone to sharp intraday swings on modest volume. The absence of any news in the Yahoo Finance RSS feed over the past 48 hours suggests the move was not driven by a major press release, clinical trial result, regulatory decision, or earnings report that would typically be captured in financial news aggregators. For companies of this size and sector, typical catalysts include FDA decisions on their Hemopurifier device platform, clinical trial outcomes, partnership announcements, or shifts in cash runway guidance. Without headline evidence, the decline could reflect profit-taking after a recent run, a sector-wide biotech pullback, short-covering reversal, or a delayed announcement not yet syndicated. The rank as the 14th biggest loser suggests a move of this magnitude occurred market-wide rather than in isolation, which might point to broader sector or market dynamics rather than company-specific news.

AMPGR

Amplitech Group, Inc. Series A Right

$0.55−$0.18

-24.3%

NASDAQ

No news headlines are available for the last 48 hours to explain the 24.32% drop in AMPGR, so the cause cannot be determined from provided information.

The absence of any news in the last 48 hours makes it impossible to identify a specific catalyst for today's sharp decline. AMPGR is a Series A Right offering from Amplitech Group, a microcap defense and aerospace supplier. Rights offerings are often volatile instruments with limited liquidity, and single-day swings of 20%+ can occur from relatively modest volume shifts or technical factors rather than fundamental news. Possible causes include profit-taking after a recent run, broader microcap selloff sentiment, adverse rumors not yet in formal headlines, or simply thin liquidity amplifying normal trading. Without corroborating news or concrete company-specific information, any specific explanation would be speculation.

CODX

Co-Diagnostics, Inc.Healthcare

$8.53−$2.66

-23.8%

NASDAQ · Mkt cap $6.9 M

Co-Diagnostics fell 23.77% likely due to disappointing Q4 2025 earnings results or guidance released on May 27, though the actual financial details are not provided in the available headlines.

Two news items appeared in the past 48 hours. One headline from May 28 mentions Co-Diagnostics as a potential national security diagnostic pick related to biodefense strategies, which is broadly positive framing. However, the more proximate catalyst is the May 27 Q4 2025 earnings release, which triggered the sell-off on May 29. The earnings transcript headline provides no specific numbers, beats, misses, or guidance revisions, so the exact nature of the disappointment remains unclear. The timing strongly suggests the earnings announcement or the market's reaction to disclosed financial results caused the decline, but without the actual earnings data, guidance changes, or management commentary details, we cannot identify the specific shortfall that prompted such a sharp 24% drop. This magnitude of loss typically reflects either significantly missed expectations, negative forward guidance, or both.

SMCZ

Daily Target 2X Short SMCI ETF

$6.23−$1.91

-23.5%

NASDAQ

No news headlines were found in the last 48 hours, but SMCZ is a 2X short leveraged ETF tracking Super Micro Computer (SMCI), so a 23% drop in SMCZ indicates a sharp rally in SMCI likely driven by positive corporate or market sentiment.

SMCZ is an inverse leveraged ETF with daily 2X short exposure to SMCI. When the underlying stock rallies strongly, inverse leveraged ETFs decline proportionally and amplified. A 23% drop in SMCZ reflects roughly an 11-12% gain in SMCI on the day, adjusted for the leverage multiple and daily rebalancing decay. Without news headlines available, the underlying cause of SMCI's strength is unknown, but common catalysts for semiconductor and AI-infrastructure plays like Super Micro include positive earnings surprises, data center demand signals, AI adoption tailwinds, analyst upgrades, or broad sector rotation into hardware beneficiaries. The absence of news does not rule out a significant corporate event or market sentiment shift that simply was not yet captured in the RSS feed at the time of this snapshot.

OCS

Oculis Holding AGHealthcare

$22.71−$6.95

-23.4%

NASDAQ · Mkt cap $754 M

Oculis announced that its Phase 3 trials for OCS-01 eye drops in diabetic macular edema failed to meet the primary endpoint, prompting the company to abandon FDA filing efforts for this program, causing the 23% stock drop.

The headlines establish a clear and material clinical setback. Oculis ran two Phase 3 trials (DIAMOND-1 and DIAMOND-2) testing OCS-01 as a potential treatment for diabetic macular edema, a significant ophthalmology market opportunity. Both trials missed their primary efficacy endpoint of mean change in best corrected visual acuity at 52 weeks, leading the company to halt plans to file with the FDA. While one headline mentions a secondary endpoint on retinal thickness showed "substantial and persistent reduction," the failure to meet the primary visual acuity measure appears to have been decisive for the FDA filing decision. For a clinical-stage biotech company, a late-stage trial failure eliminates a key revenue catalyst, eliminates a previously anticipated asset, and typically forces investors to reassess the company's pipeline, balance sheet runway, and likelihood of future success. The magnitude of the drop reflects the importance of this program to the investment thesis.

AMBA

Ambarella, Inc.Technology

$72.18−$19.66

-21.4%

NASDAQ · Mkt cap $2.9 B

Ambarella fell 21% despite beating Q1 earnings estimates, meeting guidance, posting record automotive revenue, and announcing an $800M partnership with Hanwha, suggesting the stock had already priced in these positives and investors are disappointed by forward outlook or valuation after the recen…

The earnings headlines are uniformly positive: Q1 revenues rose 16.9% to $100.4M, automotive reached record levels, the company beat earnings estimates by 4.76%, and a major $800M long-term agreement with Hanwha was announced. However, the stock price had surged 44.1% over the preceding seven days and was trading at $91.84 before the earnings release. A 21% drop on good news typically indicates either disappointing forward guidance, margin concerns, or a classic "sell the news" dynamic where investors who bought ahead of earnings are taking profits at resistance levels. One article explicitly flagged valuation concerns, asking whether $91.84 was overpriced. Management also mentioned challenges in consumer IoT and cash flow management, which may have tempered enthusiasm despite the automotive strength and AI tailwinds.

DTSQR

DT Cloud Star Acquisition Corporation

$0.12−$0.03

-20.1%

NASDAQ

No news headlines were found in the last 48 hours, so the 20% intraday drop likely reflects either technical selling pressure, a delayed market reaction to prior news, or general weakness in SPAC equities.

DT Cloud Star Acquisition Corporation is a SPAC (special purpose acquisition company), a structure that typically trades under pressure when broader market conditions deteriorate, redemption risk rises, or merger timelines slip. The absence of recent news does not rule out earlier announcements—earnings misses, insider selling, shareholder vote delays, or merger deal complications from days or weeks prior could still be driving current price action. SPACs in particular are sensitive to changes in interest rates and sentiment toward blank-check vehicles. Without fresh headlines, the decline is most likely either a continuation of an earlier negative catalyst or a reflection of general SPAC sector weakness and redemption flows.

SBFM

Sunshine Biopharma, Inc.Healthcare

$0.25−$0.06

-19.8%

NASDAQ · Mkt cap $4.5 M

Sunshine Biopharma fell 19.84% on May 29, likely driven by a reverse stock split announcement on May 28 combined with investor concern about dilution or listing maintenance pressures, despite a concurrent patent issuance that would normally be viewed as positive.

The company announced a reverse stock split on May 28 to maintain NASDAQ listing compliance, which typically signals the stock had fallen below minimum price thresholds and suggests underlying business weakness or market skepticism. While the same day brought a patent announcement for a novel coronavirus treatment, patent issuance alone rarely drives meaningful upside in early-stage biotech unless accompanied by partnership news or clinical validation. The timing and magnitude of the decline suggests the reverse split announcement—a bearish signal of delisting risk—outweighed the patent news in investor perception. Reverse splits often precede further declines as they can indicate desperation and trigger mechanical selling by funds with minimum price requirements. The patent may have been overshadowed by concerns about the company's ability to maintain listing standards.

ATPC

Agape ATP CorporationConsumer Defensive

$4.87−$1.20

-19.8%

NASDAQ · Mkt cap $2.5 M

No news headlines appeared in the last 48 hours, so the 19.77% drop likely stems from an earnings miss, corporate announcement, sector headwind, or technical selling that has not yet surfaced in public reports.

The absence of any news in the RSS feed over the past 48 hours makes it difficult to pinpoint a specific catalyst for ATPC's sharp 19.77% decline to $4.87. This is a small-cap biotech or life-sciences name based on the ticker and company name, which typically responds to clinical trial results, regulatory decisions, funding announcements, or cash burn concerns. Given the magnitude of the move and the rank among daily losers, the trigger was likely material and company-specific rather than purely technical. Possibilities include a negative trial readout, delayed or failed regulatory filing, insider selling, analyst downgrade with new information, or a cash position update that raised going-concern questions. Without access to the specific news that drove this move, the cause remains in the inference category.

PHGE

BiomX Inc.Industrials

$1.26−$0.30

-19.2%

AMEX · Mkt cap $1.5 M

No headlines were published in the last 48 hours for BiomX, so the 19% decline cannot be attributed to disclosed news; the drop likely reflects either a delayed market reaction to an earlier announcement, technical selling, or unreported corporate news.

BiomX is a clinical-stage biopharmaceutical company focused on phage therapy, a high-risk category that is typically sensitive to clinical trial outcomes, funding announcements, and regulatory developments. The absence of any recent headlines in the provided news feed makes it impossible to point to a specific catalyst. For small-cap biotech stocks trading at $1.26, declines of this magnitude can result from several common drivers: delayed reaction to an earnings or clinical trial update issued before the 48-hour window, short-seller activity or technical breakdown through support levels, insider selling or warrant dilution, funding pressure, or failure to meet a key milestone. Without confirmed news, attributing the move to any particular event would be speculation. The stock's ranking as the 23rd largest loser suggests broad market participation in the sell-off, which is consistent with either company-specific bad news or a sector-wide downturn in biotech equities.

CPSH

CPS Technologies CorporationTechnology

$9.02−$2.08

-18.7%

NASDAQ · Mkt cap $77 M

CPS Technologies announced a $9.6 million at-the-market stock offering on May 28, which triggered an 18.74% drop the next day as dilution concerns and selling pressure hit the stock.

The headline establishes that CPS Technologies entered into definitive securities purchase agreements for a registered direct offering of common stock priced at-the-market under Nasdaq rules, totaling $9.6 million. This type of announcement typically causes immediate downward pressure for two reasons: (1) shareholder dilution from the issuance of new shares, and (2) negative sentiment around the company's need to raise capital, which may signal financial stress or lack of alternative funding options. The timing between the May 28 announcement and the May 29 price action (the next trading day) is consistent with market reaction to dilutive equity offerings. The stock's ranking as the 24th biggest loser on the day suggests this was a significant driver of its decline relative to the broader market.

PLTZ

Daily Target 2X Short PLTR ETF

$21.81−$4.96

-18.5%

NASDAQ

No news headlines were found in the last 48 hours, but PLTZ is a 2X leveraged inverse ETF on Palantir, so a -18.53% drop likely reflects a sharp rally in the underlying PLTR stock that gets amplified in reverse by the fund's structure.

PLTZ is a daily target 2X short ETF, meaning it is designed to move -2X relative to its underlying asset, Palantir Technologies (PLTR). With no recent news provided, we cannot identify a specific catalyst. However, the mechanics of this security are instructive: a roughly +9% move in PLTR would produce a -18% move in PLTZ before accounting for daily reset decay. The magnitude of today's loss is consistent with a significant rally in Palantir. Without headlines, the cause of that rally is unknown, but possibilities include positive earnings results, a major contract announcement, insider buying, sector rotation into AI/defense names, or broad-based tech strength. Leveraged inverse ETFs also experience daily rebalancing slippage, especially in volatile markets, which can amplify losses independently of the underlying.

TNMG

TNL MediageneCommunication Services

$0.63−$0.14

-18.2%

NASDAQ · Mkt cap $1.1 M

No news was reported in the last 48 hours for TNMG, so the 18.22% drop likely reflects a delayed market reaction to an earlier announcement, technical selling pressure, or undisclosed company developments.

The absence of any headlines in Yahoo Finance's recent coverage over the past two days makes it impossible to pinpoint a specific catalyst for today's sharp decline. TNMG is a micro-cap stock trading at $0.63, which typically means limited analyst coverage and infrequent headlines. For stocks in this category, large single-day drops often stem from one of several sources: delayed reactions to earnings misses or guidance cuts announced earlier in the week; insider selling or dilutive financing announcements; sector-wide selloffs affecting biotech or media companies; or technical breakdown of support levels triggering algorithmic selling. Without concrete news, we cannot distinguish between these possibilities. The lack of coverage itself is notable for a company down 18% in a single day, suggesting either that the market reaction preceded the news cycle or that the move was driven by factors outside traditional press releases.

YYGH

YY Group Holding LimitedIndustrials

$0.19−$0.04

-18.1%

NASDAQ · Mkt cap $4.5 M

YY Group announced estimated assets of $37.6M and net assets per share of $4.03 as of April 30, 2026, but no market-moving catalyst or negative catalyst is evident in the headlines; the 18% drop likely reflects broader market sentiment, technical selling, or undisclosed news.

The only news provided is a routine asset and book value disclosure from May 27, 2026, showing total assets of $37.6M and net asset value of $4.03 per share against a current trading price of $0.19. This represents a massive discount to book value, which is unusual but was disclosed in the announcement itself rather than being new negative information. The announcement appears routine and informational. No earnings surprise, guidance miss, regulatory action, or material contract loss is mentioned. The 18% single-day drop on May 29 against a stock already trading at a steep discount to book value suggests either (a) technical selling pressure in a deeply distressed name, (b) a market-wide micro-cap selloff, (c) undisclosed news not captured in the RSS feed, or (d) reaction to the asset figures themselves if investors viewed them as worse than expected despite the formal announcement.

AMST

Amesite Inc.Technology

$1.41−$0.31

-18.0%

NASDAQ · Mkt cap $6.2 M

No news headlines appeared in the last 48 hours, so the 18% drop cannot be directly attributed to a specific announced event. The decline likely stems from technical selling, sector pressure, or undisclosed company developments.

Amesite Inc. dropped 18% on May 29 with zero news coverage in the preceding 48 hours according to the Yahoo Finance RSS feed provided. This disconnect between a material move and absence of public headlines is common in smaller-cap stocks and can reflect several dynamics. First, technical factors such as momentum selling, option expiration effects, or liquidation in a broader market downturn could explain the move. Second, the stock may have experienced a private development, unconfirmed rumor, or regulatory event not yet picked up by major news wires. Third, sector-wide pressure in educational technology or AI-related equities (Amesite's typical classification) could have dragged the stock down without company-specific news. Without additional context on the company's fundamentals, short interest, or broader market conditions on that date, a precise root cause remains elusive.

NL Industries, Inc.Industrials

$6.07−$1.29

-17.5%

NYSE · Mkt cap $288 M

About NLI Holdings, Inc.

Listed in this day's movers as “NL Industries, Inc.” — the company profile carries a different name (rename, or the ticker changed hands). The read below follows the profile.

NL Industries, Inc., through its subsidiary CompX International Inc., is a global and domestic manufacturer specializing in diverse component products. The company provides an extensive portfolio of mechanical and electronic locking mechanisms. This range includes various cabinet locks, such as classic disc tumbler and pin tumbler designs, alongside modern electronic options like CompX eLock and StealthLock systems. These security solutions are integral to a wide array of applications, including ignition systems, mailboxes, office furniture (file and desk cabinets), tool storage, integrated inventory and access control for secure narcotics boxes, vending and cash containment systems, medical cabinetry, electronic circuit panels, general storage compartments, and gas station security. Beyond locking devices, NL Industries also supplies a broad selection of original equipment and aftermarket components, primarily for performance and ski/wakeboard boats. These offerings include stainless steel exhaust systems such as headers, pipes, and mufflers, as well as other exhaust-related parts. The company also provides instrumentation like GPS speedometers and tachometers, mechanical and electronic controls and throttles, and specialized marine accessories. The latter category encompasses wake enhancement devices, trim tabs, steering wheels, various billet aluminum accessories, grab handles, and pin cleats. Additionally, they offer electrical components such as dash panels, LED indicators, and wiring harnesses. Complementing its product lines, the company also delivers insurance brokerage and risk management services. NL Industries distributes its component products directly to original equipment manufacturers and leverages a network of distributors. Founded in 1891, NL Industries, Inc. is based in Dallas, Texas, and operates as a subsidiary of Valhi, Inc.

Security & Protection Services · nl-ind.com

No news headlines were available in the last 48 hours to explain NL Industries' 17.53% drop on May 29, 2026. The cause remains unclear without additional reporting.

NL Industries experienced a significant single-day decline of 17.53% with no recent news coverage provided to account for the move. This is a gap between the magnitude of the price action and the information available. For a specialty chemicals and materials company like NL, typical catalysts that could drive such a decline include earnings disappointment or guidance reduction, negative commentary on cyclical end-markets (construction, automotive, industrial), adverse regulatory or environmental developments, cost inflation pressures, or deterioration in underlying commodity prices. Alternatively, the move could reflect delayed market reaction to news released earlier than the 48-hour window, technical selling triggered by a support break, or broader sector weakness. Without confirmed headlines, any specific explanation remains inference rather than fact.

ATON

AlphaTON Capital Corp.Healthcare

$0.37−$0.07

-17.0%

NASDAQ · Mkt cap $667 K

No news headlines were found in the last 48 hours to explain ATON's 17% decline, leaving the specific catalyst unclear though the stock may be responding to a delayed announcement or technical shift.

AlphaTON Capital Corp. is a blank-check acquisition vehicle (SPAC), a class of security particularly sensitive to market sentiment, redemption activity, and deal timing uncertainty. The absence of any news in the 48-hour window preceding a 17% drop suggests either a market-wide pullback affecting micro-cap SPACs, redemption pressure from shareholders, a delayed or leaked announcement about deal terms or timeline, or technical selling from a specific event outside the news cycle captured here. SPACs of this size trade on deal prospects and market appetite for blank-check vehicles, both of which can shift sharply on sentiment alone. Without a specific headline, we cannot determine whether this is announcement-driven, technical, or related to SPAC-sector dynamics more broadly.

GMEX

GMEX ROBOTICS CORPORATION Class ATechnology

$1.47−$0.30

-16.9%

NASDAQ · Mkt cap $1.0 M

GMEX Robotics fell 16.95% following a shareholder letter released on May 28, but the letter's full contents were not disclosed in available headlines, making the specific trigger unclear.

The only news item provided is a shareholder letter from GMEX Robotics issued on May 28, 2026, titled "Powering the Next Generation of Intelligent Machines." The headline and dateline are present, but the actual content of the letter is not included in the RSS feed excerpt. Without knowing what management disclosed regarding financial performance, guidance, product delays, capital raises, or other material developments, we cannot definitively link the 16.95% decline to specific revelations. The timing is suggestive—the letter was released May 28 and the stock dropped May 29—but the mechanism remains obscure. For micro-cap robotics stocks, typical negative catalysts include disappointing revenue or margin guidance, cash burn concerns, delayed product launches, or dilutive financing announcements. The shareholder letter may have contained any of these, or the drop may reflect broader sentiment unrelated to this announcement.

SUUN

PowerBank CorporationUtilities

$0.86−$0.18

-16.9%

NASDAQ · Mkt cap $27 M

PowerBank announced a hybrid energy storage and solar project in Genesee, New York on May 28, but the stock dropped 16.88% the next day, suggesting the market either found the project underwhelming or reacted to factors unrelated to this positive operational news.

The only headline provided is a project announcement from May 28, which is typically positive for energy infrastructure companies and does not on its face explain a sharp 16.88% decline. The announcement describes PowerBank executing a hybrid BESS (battery energy storage system) and solar project, which aligns with the company's stated business focus in North American energy infrastructure. However, the headline excerpt is truncated and lacks key financial details: project size, revenue magnitude, timeline, margins, or whether it met investor expectations. Possible explanations include that investors found the project terms unfavorable, the company issued guidance that disappointed despite the announcement, or the sell-off reflects broader market forces (sector rotation, liquidity event, or short covering) unrelated to this specific news.

HTCO

High-Trend International GroupIndustrials

$2.62−$0.53

-16.8%

NASDAQ · Mkt cap $26 M

No news headlines appeared in the last 48 hours, so the 16.83% decline cannot be attributed to a specific announced event; the drop likely reflects technical selling, market-wide pressure, or untracked corporate developments.

The absence of any Yahoo Finance headlines in the past two days makes it impossible to pinpoint a concrete news-driven catalyst for HTCO's sharp 16.83% decline. This is particularly notable given the stock ranks as the 33rd biggest loser on the day, suggesting meaningful selling pressure. For a micro-cap or lower-liquidity stock like HTCO, declines of this magnitude without reported headlines could stem from several sources: a negative earnings report or guidance cut that has not yet been indexed in the RSS feed lag, technical breakdown below key support levels triggering algorithmic or momentum-driven selling, broad sector weakness in whatever industry HTCO operates in, insider selling, or delayed news from a corporate announcement made outside of major news channels. Without specific information about HTCO's business, recent financial metrics, or sector context, the most honest assessment is that the driver remains unknown.

TDTH

Trident Digital Tech Holdings LtdTechnology

$2.57−$0.49

-16.0%

NASDAQ · Mkt cap $2.3 B

TDTH fell 16% despite announcing a binding LOI with Digital Innovations Group to deploy its IRMA AI engine across Asia-Pacific, suggesting market skepticism about deal terms, execution risk, or broader sector headwinds rather than positive reception to the news.

On May 28, Trident announced a binding letter of intent with a U.S.-based firm to expand its AI platform into Asia-Pacific markets, positioning this as advancing the company's scalable SaaS and enterprise automation strategy. This is conventionally positive M&A-adjacent news. However, the stock declined 16% by the next day, ranking among the day's 34 biggest losers. The only other headline references a broader decline in Asian equities and ADRs on May 28 morning, which could explain some downward pressure on TDTH as an Asia-focused play. The mismatch between the LOI announcement and the sharp decline suggests either (1) market concern about deal credibility, valuation, or dilution, (2) the LOI being viewed as insufficient relative to growth expectations, (3) a delayed market reaction to negative information not captured in these headlines, or (4) technical selling pressure in a weakness-prone micro-cap. The news itself does not establish a concrete negative catalyst.

WKHS

Workhorse Group Inc.Consumer Cyclical

$3.83−$0.73

-16.0%

NASDAQ · Mkt cap $36 M

No news headlines are available in the last 48 hours to explain the 16% decline, so the cause remains unclear; the drop could reflect delayed reactions to prior announcements, technical selling, or broader market headwinds affecting the electric vehicle sector.

Workhorse Group experienced a significant 16% single-day drop with no corresponding news headlines in the 48-hour window. This absence of reporting makes root-cause identification difficult. Workhorse is a pre-revenue or early-stage electric vehicle manufacturer with a history of volatility and investor sensitivity to production delays, funding concerns, and competitive pressures. For stocks in this category, major declines without contemporaneous news often reflect delayed market reactions to prior earnings or guidance, short-seller activity or research reports released earlier, broader sector weakness in EV stocks, or technical breakdown through support levels. Without access to headlines or filings from earlier in the week, we cannot confirm which of these categories applies here.

BNRG

Brenmiller Energy LtdUtilities

$1.66−$0.31

-15.7%

MRAM

Everspin Technologies, Inc.Technology

$26.38−$4.88

-15.6%

NASDAQ · Mkt cap $425 M

No news headlines were found in the last 48 hours, so the 15.61% drop cannot be attributed to any publicly announced event; semiconductor and specialty memory stocks often react to broad sector weakness, earnings whispers, or macro shifts in memory demand.

Everspin Technologies experienced a sharp single-day decline of over 15% with zero news coverage in the prior 48 hours. This suggests the move was either driven by information not yet reflected in headline feeds, general sector rotation out of semiconductor stocks, or a market-wide event unrelated to company-specific news. MRAM (magnetoresistive random-access memory) companies are cyclical and sensitive to memory market conditions, industrial demand signals, and competitive pricing pressure. Without headlines, the most probable triggers would be a broad selloff in the semiconductor or storage sectors, negative guidance revision (possibly from a competitor), or a delayed earnings or earnings-call statement that hadn't yet been indexed by news aggregators at snapshot time.

GAP

The Gap, Inc.Consumer Cyclical

$21.17−$3.83

-15.3%

NYSE · Mkt cap $7.9 B

Gap Inc. plunged 15% after missing Q1 earnings estimates and slashing its full-year sales guidance, citing margin pressure from tariffs and weakness at Old Navy, which underperformed analyst expectations by a significant margin.

Gap reported Q1 earnings and sales that missed analyst forecasts. More importantly, the company issued a cautious Q2 outlook and trimmed its full-year revenue forecast, signaling material deterioration in near-term demand. The core problem appears to be Old Navy, Gap's largest brand by volume, which saw comparable sales grow only 1% versus analyst expectations of 3%. The headliner attributed internal execution issues and competitive pressure from off-price retailers as factors, while tariffs and growth spending further pressured margins. Although the namesake Gap brand performed solidly, the Old Navy shortfall and weakened forward guidance triggered the sharp sell-off. The broader market was modestly positive on the day, so this was stock-specific weakness driven by disappointing guidance rather than a market-wide downturn.

ICG

Intchains Group LimitedTechnology

$0.83−$0.15

-15.3%

NASDAQ · Mkt cap $53 M

No news headlines were found in the last 48 hours, so the 15.31% drop cannot be attributed to a specific announced event. The move likely reflects technical selling, market-wide sentiment, or untracked rumors in a thinly-traded micro-cap stock.

ICG experienced a sharp single-day decline of 15.31% on May 29, 2026, but no news was published to Yahoo Finance in the preceding 48 hours. This absence of headline coverage makes it difficult to pinpoint a definitive catalyst. In stocks of this size and liquidity profile—trading near $0.83 with low institutional following—price moves are often driven by factors not immediately visible to mainstream financial media, such as insider selling, deteriorating technical support, untracked short-seller reports, or broad micro-cap repricing. It is also possible that a material announcement was released outside normal news feeds or that negative information circulated on social media or bulletin boards ahead of formal press releases. Without access to company filings, insider transactions, or real-time trading data, attributing this specific move requires inference rather than fact.

TDWDR

Tailwind 2.0 Acquisition Corp. Rights

$0.11−$0.02

-15.0%

NASDAQ

No recent news was reported for TDWDR in the last 48 hours, so the 15% drop likely reflects thin trading liquidity typical of SPAC rights or market-wide weakness on 2026-05-29.

Tailwind 2.0 Acquisition Corp. Rights are a low-priced, low-volume security common in the SPAC market. The absence of any headlines in the prior 48 hours suggests the decline was not driven by company-specific news. Rights offerings on blank-check companies are structurally volatile and illiquid, making them susceptible to sharp intraday moves on minimal volume or technical factors. The drop could reflect profit-taking after recent strength, a broader market pullback on the snapshot date, or simply a bid-ask spread widening in a thinly traded instrument. Without news or data on trading volume, we cannot determine whether this represents meaningful selling or merely the typical volatility of a micro-cap derivative security.

QUCY

Mainz Biomed N.V.Healthcare

$2.54−$0.44

-14.9%

NASDAQ · Mkt cap $15 M

The provided news headline concerns Quantum Cyber, a defense-technology company, not Mainz Biomed (QUCY), a diagnostic company, so the 14.88% decline likely stems from unrelated market factors, earnings disappointment, or sector headwinds.

The news item in the feed discusses Quantum Cyber's plans to establish a U.S. manufacturing complex for drone and autonomous systems—a completely different company and industry from Mainz Biomed, which focuses on colorectal cancer diagnostics. This mismatch suggests either a data error in the news feed or that the decline is unconnected to the headline provided. For a diagnostic biotech stock like QUCY, typical catalysts for sharp single-day drops include clinical trial setbacks, regulatory rejection, downward revenue guidance, analyst downgrades, funding dilution, or broader biotech sector selloffs. Without confirmed news tied directly to Mainz Biomed, the cause remains speculative. The magnitude of the loss (14.88%) implies material adverse information rather than routine volatility.

JLHL

Julong Holding Limited Class A Ordinary SharesIndustrials

$19.59−$3.41

-14.8%

NASDAQ · Mkt cap $152 M

No news directly explaining the 14.83% drop was provided; JLHL may have experienced a broader market correction, sector rotation, or undisclosed company-specific event unrelated to the generic market outlook article referenced.

The only recent headline provided is a generic article about undiscovered gems in the US market, which offers no information about JLHL specifically and does not explain why this stock would fall sharply on a day when the broader market sentiment appears positive. The article mentions the US market climbed 1.8% in a week and is up 28% annually, suggesting a favorable backdrop that would not naturally drive a major single-stock decline. JLHL's 14.83% drop as the 42nd biggest loser likely stems from company-specific factors such as disappointing earnings or guidance, sector headwinds affecting Chinese equities or ADRs, insider selling, analyst downgrades, or technical breakdown, but none of these are established by the available headlines. Without targeted news about JLHL itself, the cause remains speculative.

ASTS

AST SpaceMobile, Inc.Technology

$113.41−$19.68

-14.8%

NASDAQ · Mkt cap $23 B

AST SpaceMobile fell 14.79% after Blue Origin's New Glenn rocket exploded during testing on May 28, triggering launch delay concerns and a Deutsche Bank downgrade from Buy to Hold, raising execution risk for satellite-connectivity missions.

The headlines establish a clear causal chain. Blue Origin suffered a catastrophic explosion of its New Glenn rocket during a hotfire test at Cape Canaveral late Thursday, May 28. This event directly triggered a sector selloff in space stocks on May 29. AST SpaceMobile was hit particularly hard because the company relies on rocket launches to deploy its satellite network, and any delay in launch vehicle availability represents material execution risk. Deutsche Bank's downgrade to Hold with a price-target cut from $110 to $106 reinforced the selloff, citing launch concerns. The decline from the initial 17-18% drop to the final 14.79% suggests some modest recovery during the trading session, but the fundamental concern remains that a major launch provider has suffered a significant setback, potentially pushing back ASTS's satellite deployment timeline.

SDOT

Sadot Group Inc.Consumer Defensive

$2.73−$0.46

-14.4%

NASDAQ · Mkt cap $11 M

No news headlines were published in the last 48 hours, so the 14.42% drop cannot be directly attributed to a specific announced event. The decline likely reflects either technical selling, a delayed market reaction to earlier news, or broader sector pressure.

With no recent headlines available to explain the move, the cause remains unclear from the information provided. A decline of this magnitude in a lower-capitalization NASDAQ stock like Sadot Group typically reflects one of several scenarios: deteriorating technicals or support levels breaking, delayed market absorption of news released more than 48 hours prior, sector-wide pressure affecting similar companies, or negative sentiment driven by rumors or institutional repositioning not yet reflected in major news feeds. Without access to the company's fundamentals, recent earnings dates, or analyst downgrades, attributing the drop to a specific catalyst would be speculation. The absence of any headline coverage itself is notable and could suggest either a lack of material news or that coverage has not yet reached major financial news aggregators.

EGG

Enigmatig LimitedIndustrials

$7.60−$1.28

-14.4%

AMEX · Mkt cap $87 M

EGG fell 14.38% with no news headlines in the last 48 hours, making it impossible to identify a specific catalyst; the move likely reflects technical selling, sector rotation, or undisclosed company-specific developments.

No headlines were found in the Yahoo Finance RSS feed for the last 48 hours surrounding this 14.38% decline in EGG stock. Without a documented news event such as earnings results, guidance revisions, regulatory actions, or management changes, the cause of this sharp single-day drop cannot be pinned to a specific catalyst. For smaller-cap stocks like those trading on AMEX, common drivers of unexplained moves include technical support breaks, algorithmic liquidations following broader market weakness, changes in short interest, insider selling, or delayed announcements that may not immediately appear in major news feeds. The stock's rank as the 45th biggest loser suggests sector-wide weakness is possible but not definitive without sector context. Until additional information surfaces, the actual trigger remains speculative.

KFIIR

K&F Growth Acquisition Corp. II Rights

$0.12−$0.02

-14.3%

NASDAQ

No news headlines were found in the last 48 hours to explain the 14.29% drop in KFIIR, a SPAC rights unit. The decline likely reflects broader market weakness in blank-check vehicles or a decline in the underlying acquisition target's prospects.

K&F Growth Acquisition Corp. II Rights (KFIIR) is a SPAC rights unit, a specialized security that trades independently of the common stock and warrants. The absence of any news in the last 48 hours makes it difficult to pinpoint a specific catalyst. SPAC rights are particularly sensitive to changes in sentiment toward the blank-check sector broadly, redemption expectations, or developments concerning the target company if a merger has been announced. Since no headlines are available, the decline could reflect sector-wide pressure on SPACs due to regulatory scrutiny, rising interest rates affecting blank-check valuations, or company-specific news that has not yet been indexed by the news feed. Without additional context on the status of the merger, deal terms, or recent statements from management, the exact cause remains opaque.

GOVX

GeoVax Labs, Inc.Healthcare

$2.06−$0.34

-14.2%

NASDAQ · Mkt cap $3.1 M

No relevant news about GeoVax was provided; the 14% drop likely reflects broad biotech selling pressure, sector rotation, or company-specific developments not captured in the available headlines.

The single headline provided discusses Co-Diagnostics and decentralized diagnostic networks for biodefense, not GeoVax Labs specifically. While both are biotech names, this article does not establish a direct catalyst for GOVX's decline. For a small-cap biotech stock like GeoVax, typical drivers of sharp single-day losses include clinical trial setbacks, financing dilution announcements, insider selling, loss of partnership value, cash runway concerns, or broader sector de-risking. Without news directly tied to GOVX, the move may reflect either company-specific news absent from this feed or macro biotech sector weakness that hit smaller players harder than large caps.

BOT

RoboStrategy, Inc. Common StockFinancial Services

$24.88−$4.10

-14.1%

NCRA

Nocera, Inc.Consumer Defensive

$0.22−$0.04

-14.1%

NASDAQ · Mkt cap $3.2 M

No news headlines were available in the last 48 hours to explain Nocera's 14.09% decline, so the cause remains unclear without additional information about the company or broader market conditions.

Nocera, Inc. dropped 14.09% to $0.22 per share with no identifiable news catalyst in the provided headline feed. At this price level, the stock is typically more susceptible to liquidity constraints, short-term technical selling, and sentiment shifts on minimal volume. Possible drivers include delayed negative announcements not yet indexed in the RSS feed, deterioration in cash position or upcoming capital raises that dilute shareholders, sector-wide pressure on micro-cap or speculative positions, or accumulation of negative sentiment from prior quarters that finally triggered a sell-off. Without access to current filings, insider activity, or broader market commentary, the precise catalyst cannot be determined from available evidence alone.